• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Up 0.14%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqGM
    6.48 Down 0.05(0.77%) Jul 29, 4:00PM EDT
    |After Hours : 6.48 Down 0.00 (0.02%) Jul 29, 4:46PM EDT
    Prev Close:6.53
    Open:6.49
    Bid:6.00 x 600
    Ask:N/A
    1y Target Est:20.42
    Beta:3.43691
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:6.41 - 6.66
    52wk Range:3.50 - 14.73
    Volume:147,914
    Avg Vol (3m):231,040
    Market Cap:206.76M
    P/E (ttm):N/A
    EPS (ttm):-0.89
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVDown 0.77%206.76M
    ALSE 0.00%398.26K
    ACORUp 1.32%1.16B
    STEMDown 1.79%4.37M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.91
    Quarterly EPS Est (Jun-16) :-0.22
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback